Can some breast cancer patients skip extra radiation after surgery?
Part of Cancer, Skin clinical trials.
This trial tests whether women who have a complete response to chemotherapy before breast-conserving surgery can safely skip a special radiation boost to the tumor bed. It aims to reduce unnecessary treatment side effects while maintaining good outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have invasive breast cancer that was a single tumor, stages T1-3 and N0-3a at diagnosis.
- You must have completed standard chemotherapy based on your cancer type and had a complete response (no cancer cells left) in the breast at surgery.
- You must have had breast-conserving surgery with clear margins of at least 1 mm.
- You must be between 30 and 75 years old and in good general health (ECOG 0-1).
- You must not have had prior chest radiation, other cancers, or known BRCA gene mutations.
- You must be able to start radiation within 8 weeks after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
This trial tests whether women and men with advanced, non-metastatic breast cancer can safely skip an extra radiation boost to the lymph nodes if their tumors respond well to pre-surgery chemotherapy or targeted therapy. The goal is to reduce side effects while keeping cancer control.
This trial is for women 50 and older with early-stage, hormone-positive or HER2-positive breast cancer. It tests whether it is safe to skip radiation therapy after a lumpectomy if an MRI before surgery shows the breast tissue looks a certain way.
This trial tests whether some women with low-risk breast cancer that has spread to a few lymph nodes can safely skip radiation therapy after surgery. It aims to reduce side effects while keeping the cancer from coming back.
This trial tests whether women with breast cancer who had a complete or near-complete response to chemotherapy before mastectomy need radiation therapy after surgery. It aims to see if skipping radiation is safe and can reduce side effects.
This study gives radiation to the breast before surgery to see if some people can safely delay or even skip surgery. It targets women with a small, node-negative, ER-positive breast cancer with low genetic risk.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.